Proteostasis Therapeutics
Latest round
- Series B
Last raised
- Sep 2015
Total raised
- $82M
Investors
- 8
About Proteostasis Therapeutics
Founded in 2006 and based in Massachusets, US, Proteostasis Therapeutics, Inc. operates as a developer of small molecule therapeutics designed to control the body protein homeostasis, or the Proteostasis Network. The company's products works on the treatment of cystic fibrosis, neurodegenerative diseases, and orphan diseases
Who invested in Proteostasis Therapeutics
8 investors across 2 rounds
See all investors in Proteostasis Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Proteostasis Therapeutics
Who invested in Proteostasis Therapeutics?
Proteostasis Therapeutics has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Proteostasis Therapeutics raised?
Proteostasis Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Proteostasis Therapeutics last raise money?
Proteostasis Therapeutics's most recent round on record is a Series B, in Sep 2015.
What does Proteostasis Therapeutics do?
Founded in 2006 and based in Massachusets, US, Proteostasis Therapeutics, Inc.
Where is Proteostasis Therapeutics headquartered?
Proteostasis Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Proteostasis Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Proteostasis Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Proteostasis Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.